ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 12551 to 12572 of 17925 messages
Chat Pages: Latest  513  512  511  510  509  508  507  506  505  504  503  502  Older
DateSubjectAuthorDiscuss
21/1/2021
13:40
The herds still continue to reiterate the same with a man's 'Best Friend' Twitter - I ask again how many pre-clinical trials have demonstrated safety adequacy and then faltered?

But billions and trillions are still highly likely right with such ferocious competition within BioPharma...Globally!

rebelwithacause1
21/1/2021
13:26
https://twitter.com/astrobrook/status/1352119103100772353?s=21
aaron_r
21/1/2021
12:10
'HOPE' being the given word!
I can hope for 'Everything' but it is not guaranteed now is it!

...But you still continue to miss the point or just resistant to listening. I iterate again (and no doubt will again!) - how many trials are abandoned following expansion due to untoward instances? - quite a few by my recollection!

rebelwithacause1
21/1/2021
12:07
hope to see very positive clinical trial data so we can expand the trial
yidarmytom
21/1/2021
12:02
Confidence diminishing hey, I thought its just started, surely I'm not mistaken am I!
rebelwithacause1
21/1/2021
11:58
it's been a fun engagement but we're at the end of the road bud
yidarmytom
21/1/2021
11:48
Brilliant buddy - I'm most grateful...
...But when you do 'Unfilter' not if realise I'm not SC but if you still don't believe it, read over both our comments and 'DisSect' the information as appropriate as they would in a clinical setting like yours, it may just help you realise that we are both very different...

rebelwithacause1
21/1/2021
11:43
rebs filtered, small crow filtered
yidarmytom
21/1/2021
11:32
Hehe - seriously Tom, you would rather listen to the 'Mug' that is OldApache and all his palava...that is worrying!
rebelwithacause1
21/1/2021
11:26
agreed Mark, it's fairly obvious
yidarmytom
21/1/2021
11:10
Rebelwithoutabrain is switching between his aliases now. Reb over to small crow then back to Reb again. Who does he think he's fooling. Such a sad pig of a man.
mark0419
21/1/2021
11:08
We beg to agree 100% Rebs, I am with you on that but to be fair I never said or implied it was - IF the data is good they will expand the trial (to your point earlier) and that could give a boost but it's an IF. hehe!
yidarmytom
21/1/2021
11:06
Look, I am not clinically based but I do know absolutely nothing is guaranteed here...
rebelwithacause1
21/1/2021
11:03
misunderstand the products? Tiziana do not have any products so that shows wtf you know small crow...pmsl

They have candidates in P1, 1b, & 2 trials but I doubt you have the first idea on the difference between them or the criteria you need to meet to get FDA approval to move from one phase to the next.

yidarmytom
21/1/2021
11:02
14% of pre-clinical trials are successful through to FDA approval. But we are not pre-clinical are we? What do you think the % is for P1 or P2 to get to P3, IND or NDA approval?
yidarmytom
21/1/2021
11:01
yidarmy, so ... er .... how did such an expert manage to misunderstand the products of this one? And, perhaps your consultancy was in a non-clinical area? Managing the lift?
small crow
21/1/2021
10:59
Global percentages would be a start Tom...
Four years ago hey Lean, it would be helpful to assume the figures within the last couple of years when all things BioPharma have been blooming...

...And there you have it, not so promising right as Lean states!

rebelwithacause1
21/1/2021
10:55
In other words, 1 in 7 products managed to be utelised for the masses. Not a good percentage meethinks.
lean5gb
21/1/2021
10:54
I used to do consultancy for a U.S. based CRO so yes, I think I know a bit about clinical trials.....
yidarmytom
21/1/2021
10:52
RebelwithaCause121 Jan '21 - 10:39 - 12457 of 12462
0 0 0
So you're also aware of how many trials are abandoned following pre-initial success?

Absolutely, how much detail would you like me to go into on an example?

yidarmytom
21/1/2021
10:52
The 14% figures were admittedly 4 years old, and were for the product not to be sold on to the market.
lean5gb
21/1/2021
10:46
"I'm a specialist Biotech Investor ..." LOL
small crow
Chat Pages: Latest  513  512  511  510  509  508  507  506  505  504  503  502  Older

Your Recent History

Delayed Upgrade Clock